Naltrexone is under development for the treatment of alcohol, opioid addiction and methamphetamine use disorder (MUD). It is a long acting implantable naltrexone implant, administered by the ...

Expert Rev Clin Pharmacol. 2012;5(4):427-435. Naltrexone is relatively well tolerated, and the primary side effects are gastrointestinal discomfort. Higher doses (above 50 mg/day) have been ...

In our ongoing look at treating substance abuse in America, we turn to the most commonly used drug, and one of the deadliest: alcohol. Drinking kills more Americans every year than opioids or any ...

Among addiction researchers, however, any reduction in drinking is increasingly seen as a win. In addition to naltrexone, ...

Recent comparisons of naltrexone and acamprosate using systematic literature review conclude that, although both drugs are effective as adjuvant therapies for alcohol dependence, acamprosate is ...

Joe Breen, 38, is one of thousands of people whose experiences with GLP-1s such as Ozempic and Wegovy have radically changed their relationship with alcohol. Are these drugs the future for treating ...

For others, it reduces alcohol consumption and the cravings that trigger binge use or relapses. Naltrexone is one of three standard FDA-approved medications currently on the market to treat AUD.

There may be properties of anti-obesity medications that lead to reduced use. For example, naltrexone decreases cravings for alcohol and glucagon-like peptide-1 receptor agonists (GLP-1 RAs ...

Transcranial magnetic stimulation for alcohol use disorders is under investigation. Research to date suggests TMS could play ...

Anti-obesity medication use was associated with reduced alcohol consumption among patients in a telehealth medical weight ...